China Resources Double-Crane Pharmaceutical (SHA:600062) unit Zhongshuai Medical obtained drug registration from China's medical products regulator for acetazolamide sustained-release capsules.
The drug is used for preventing or improving symptoms of acute mountain sickness, according to a Wednesday filing with the Shanghai bourse.